A short-seller, a takeover rumor and an IPO pulled money out of AI chips
Stocks opened strong and closed at their lowest in months. The S&P 500 ETF fell 2.0% and the chip ETF 2.6% as retail traders sold AI names to buy into Anthropic's debut, and a short report on AMD tied its China exposure to a new Commerce Department export rule.
The board
| Stock | Move | Why, in one line |
|---|---|---|
| INSM | +20.6% | Bloomberg: Sanofi weighing a takeover bid |
| ANT | +17.1% | First trading day after an IPO priced above range |
| TU | +13.4% | BCE talks report raises odds of a bidding war |
| PDD | +11.0% | Profit beat from deep marketing cuts; revenue flat |
| PANW | +6.4% | Beat and raised; lifted the whole security group |
| SNEX | −26.7% | Earnings miss as retail trading income fell 56% |
| WSM | −15.2% | Slight miss, guidance held, rich valuation |
| KLAR | −12.3% | High-risk fintech sold across the board |
| NTES | −11.4% | Games revenue missed |
| TEVA | −8.7% | Head of R&D quit a week after R&D Day |
| AMD | −7.7% | Hunterbrook short report on China exposure |
The government angle
AMD lost about $67 billion in market value in an afternoon, and the timing ran through Washington. Hunterbrook published a short report at 10:27 a.m. alleging that IEIT Systems, a Chinese server maker on the U.S. blacklist, kept posting newer AMD firmware. The report also flagged $7.75 billion of China and Hong Kong revenue (22% of fiscal 2025) and $4.28 billion from Singapore, on the same day a new Commerce Department rule began requiring licenses for AI chip shipments to Singapore. AMD says it complies with export laws. The stock reversed from up 2.3% to a $489 close and kept falling after hours.
Source: 24/7 Wall St. · Hunterbrook disclosed a short position.
Elsewhere in the federal record, it was a quiet day. No listed company or subsidiary was added to or removed from the SAM.gov exclusions list. Tomorrow's Federal Register adds FAA airworthiness directives for Boeing and Airbus aircraft, and antidumping actions on Chinese shopping carts, French steel plate and Indian rail couplers. None looked market-moving.
The stories
ANT Anthropic +17.1% High confidence
The IPO priced at $83, above its $70–78 range. A delayed opening auction meant the first trade came at 11:48 a.m., at $111.50 (up 34%). It faded all afternoon to close at $97.17 on about 832 million shares.
The filing is what investors were paying for: $33.2 billion of revenue in the first nine months of 2026, up from $2.6 billion a year earlier, and $17 billion in the third quarter alone. It also disclosed about $901 billion in compute and lease commitments, the number skeptics will watch.
The ripple: Vanda Research said retail investors sold other AI stocks to fund their Anthropic shares, one reason the AI compute names fell on a day with little company news.
Sources: StockTitan · Yahoo Finance
INSM Insmed +20.6% High confidence
Bloomberg reported that Sanofi is working with advisers on a possible takeover. Talks are confidential, no deal has been reached, and one could be weeks away. Neither company confirmed. Sanofi's ADR fell about 2.4%, the usual sign that the market believes the buyer would pay up.
Why Insmed: its bronchiectasis drug Brinsupri is launching faster than expected. Third-quarter sales were $400 million of $524 million in total revenue, and the company raised the low end of its 2026 Brinsupri guidance to $1.35 billion.
Sources: Yahoo Finance · TIKR
TU Telus +13.4% High confidence
Monday's non-binding Québecor offer was worth about C$19.45 a share, a roughly 60% premium, but Telus kept trading well below it on regulatory doubts. Thursday's Globe and Mail report that BCE had held preliminary talks with Telus changed the math: two possible buyers instead of one. Québecor reaffirmed its bid, National Bank upgraded Telus, and Scotiabank said BCE's interest could force a higher offer.
Sources: BNN Bloomberg · Investing.com
PDD PDD Holdings +11.0% High confidence
Profit beat and revenue didn't. Net income was RMB 29.5 billion against RMB 24.8 billion expected, while revenue was flat at RMB 108.3 billion, short of about RMB 116 billion. Transaction-services revenue fell 12%, which reflects Temu's problems with U.S. tariffs and the end of duty-free small parcels.
The beat came from cutting sales and marketing spending by 17%, which lifted the adjusted operating margin to 30% from 25%. Management warned against assuming that lasts.
Sources: PDD results
PANW Palo Alto Networks +6.4% and the security group High confidence
Revenue rose 39% to $3.44 billion against $3.31 billion expected, and recurring revenue from newer products rose 66% to $9.73 billion. The company raised its fiscal 2027 revenue outlook to $14.52–14.57 billion, above the roughly $14.17 billion analysts expected, and agreed to buy Applied Compute for $4.5 billion in stock.
The read-through lifted the group: Okta rose 5.7%, Netskope 5.5%, Rubrik 4.1% and Zscaler 4.0%. Reuters framed it as heavier spending to defend against AI-enabled attacks.
Sources: Yahoo Finance · Reuters via WHBL
SNEX StoneX −26.7% High confidence
Revenue beat, earnings didn't. Diluted EPS was $0.66 against $0.81 expected. Year-end tax adjustments meant pre-tax income rose about 10% while net income fell 2%. Underneath, institutional income fell 25%, and retail income fell 56% as currency and CFD trading volumes dropped 17%. The company gave no new guidance to cushion it.
Sources: Investing.com transcript · Seeking Alpha
WSM Williams-Sonoma −15.2% High confidence
A one-cent miss ($2.19 against $2.21) wasn't the problem. The 47.6% gross margin included a $29 million tariff refund; without it, the margin was 46.2%, flat with last year, and higher oil prices cost about half a point. Holding full-year guidance instead of raising it leaves the holiday quarter needing roughly 10% earnings growth, for a stock that was trading at about 26 times forward earnings against a five-year average near 16.
Source: Yahoo Finance
NTES NetEase −11.4% High confidence
Revenue was RMB 27.85 billion against RMB 29.51 billion expected. Games revenue fell 8% from the second quarter on weaker in-house titles. The next big bet, Ananta, launches January 15.
Sources: Yahoo Finance · Seeking Alpha
TEVA Teva −8.7% Medium confidence
Eric Hughes, head of global R&D and chief medical officer, resigned effective immediately, one week after Teva's R&D Day and in the middle of its push from generics into new medicines. Teva named an interim lead and says the strategy is unchanged.
Sources: Seeking Alpha
Fintech: KLAR −12.3%, DAVE −11.5%, SEZL −7.7% Low confidence
We found no shared news behind the drop. Klarna had already drawn price-target cuts after its third quarter (Morgan Stanley to $14, JPMorgan to $17, BMO to $13), citing weaker European demand and softer fourth-quarter guidance. On a risk-off day, the highest-risk fintech names fell hardest.
Source: Yahoo Finance
What we couldn't explain
Zoom (−9.6%), Warby Parker (−14.5%), Nebius (−9.4%) and Cerebras (−7.6%) moved without company news we could verify. Zoom holds an early Anthropic stake and may have traded as an IPO proxy; Warby Parker had jumped 8% the day before. We'd rather say "unknown" than invent a reason.